Cargando…
Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia
BACKGROUND: The RECOVERY clinical trial reported that 6 mg of dexamethasone once daily for up to 10 days reduces the 28-day mortality in patients with coronavirus disease 2019 (COVID-19) receiving respiratory support. In our clinical setting, a fixed dose of dexamethasone has prompted the question o...
Autores principales: | Isaka, Yuri, Hirasawa, Yasutaka, Terada, Jiro, Shionoya, Yu, Takeshita, Yuichiro, Kinouchi, Toru, Koshikawa, Ken, Tajima, Hiroshi, Kinoshita, Taku, Tada, Yuji, Tatsumi, Koichiro, Tsushima, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677429/ https://www.ncbi.nlm.nih.gov/pubmed/34923122 http://dx.doi.org/10.1016/j.pupt.2021.102108 |
Ejemplares similares
-
Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: A single-center retrospective cohort study during 5th wave in Japan
por: Hirasawa, Yasutaka, et al.
Publicado: (2023) -
High-flow nasal cannula oxygen therapy in hypoxic patients with COVID-19 pneumonia: A retrospective cohort study confirming the utility of respiratory rate index
por: Takeshita, Yuichiro, et al.
Publicado: (2022) -
Elevated TAT in COVID-19 Patients with Normal D-Dimer as a Predictor of Severe Respiratory Failure: A Retrospective Analysis of 797 Patients
por: Takeshita, Yuichiro, et al.
Publicado: (2021) -
Development of a novel score model to predict hyperinflammation in COVID-19 as a forecast of optimal steroid administration timing
por: Takeshita, Yuichiro, et al.
Publicado: (2022) -
Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study
por: Takeshita, Yuichiro, et al.
Publicado: (2021)